Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites

Table 2 Pulmonary ventilation function in relation to tumor staging

Pulmonary function	Stage I	Stage II	Stage III	Stage IV
ZC^(a)	19(44.2%)	1(14.3%)	0(0.0%)	1(50%)
QD^(b)	17(39.5%)	4(57.1%)	1(33.3%)	0(0.0%)
ZZD^(c)	7(16.3%)	2(28.6%)	2(66.7%)	1(50%)
Total	43	7	3	2

^(a) Normal pulmonary function; ^(b) Mild pulmonary ventilation dysfunction; ^(c) moderate or above pulmonary ventilation dysfunction.

ISSN: 1471-2466